MANAGEMENT OF HAEMOGLOBIN DECREASE IN PATIENTS TREATED WITH ABT-450/RITONAVIR/OMBITASVIR AND DASABUVIR WITH OR WITHOUT RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS

Daniel Forton  1     Hendrik Reesink  2     David E. Bernstein  3     Thomas Sepe  4     John Vierling  5     William King     Yiran Hu     Jeffrey Enejosa     Daniel E. Cohen     Yan Luo     Marcos Pedrosa     Peter Ferenci    
1 St. George’s, University Of London, London, United Kingdom
2 Academisch Medisch Centrum, Universiteit Van Amsterdam, Amsterdam, Netherlands
3 North Shore University Hospital (brany), Manhasset, United States
4 University Gastroenterology, Providence, United States
5 St. Luke’s Episcopal Hospital / St. Luke’s Advanced Liver Therapies, Hou

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing